The 11th Asian Vaccine Conference (ASVAC 2027)

Key Topics

• Evidenced-based introduction of new vaccines
  • Health economics of vaccines
  • New vaccine introduction process
  • Programmatic issues and barriers to immunization
• Disease-specific vaccines
  • Mosquito-borne viruses e.g. Dengue, Japanese encephalitis, Zika, Malaria and Chikungunya
  • Enteric vaccines e.g. Cholera, Typhoid and Rotavirus
  • Polio
  • Respiratory viruses e.g. Influenza, Respiratory Syncitial virus
  • Hepatitic viruses
  • Measles, Mumps and Rubella
  • COVID-19
• Targeted vaccination strategies
  • Adolescents
  • Pregnant mothers
  • Elderly
  • Infancy and childhood
  • School-based programs
• Monitoring and surveillance
  • Health Information Systems and Immunization Registries
  • Disease surveillance
  • Vaccine safety monitoring and vaccine pharmacovigilance
  • Meeting and monitoring vaccination coverage targets
• Vaccines in specific settings
  • Vaccination in conflict zones and disaster areas
  • Travel vaccines
  • Vaccines for COVID-19
  • Vaccines for special groups
• Vaccine implementation
  • Communications and social mobilization
  • Advocacy
  • Immunization legislation and insurance
  • Implementation of the Global Vaccine Action Plan
• Vaccines in development
  • New and underused vaccines
  • New vaccine pipeline